Tauroursodeoxycholic acid (TUDCA) reduces apoptosis and protects against neurological injury after acute hemorrhagic stroke in rats. Reduction of brain injury underlies the wide-range neuroprotective effects of TUDCA after ICH. Thus, given its clinical safety, TUDCA may provide a potentially useful treatment in patients with hemorrhagic stroke and perhaps other acute brain injuries associated with cell death by apoptosis.
FREE DOmestic shipping for orders $150+